FDA approves Intrarosa for postmenopausal women experiencing pain during sex

"U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx> · Thu, 17 Nov 2016 08:46:01 -0600

Title:     FDA approves Intrarosa for postmenopausal women experiencing pain during sex

View as a webpage

News Release

For Immediate Release:  

Nov. 17, 2016

Media Inquiries:  

Andrea Fischer,
301-796-0393, andrea.fischer@xxxxxxxxxxx

Consumer Inquiries:  

888-INFO-FDA

FDA approves Intrarosa for
  postmenopausal women experiencing pain during sex

The U.S. Food and Drug
Administration approved Intrarosa (prasterone) to treat women experiencing
moderate to severe pain during sexual intercourse (dyspareunia), a symptom of
vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA
approved product containing the active ingredient prasterone, which is also
known as dehydroepiandrosterone (DHEA). 

###

Subscriber Services: 
Manage Preferences��|��Unsubscribe��|��Help with this service

Stay Connected:

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) � 10903 New Hampshire Ave � Silver Spring, MD 20993 � 1-888-INFO-FDA (1-888-463-6332)